KalVista Pharmaceuticals, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
KALV on Nasdaq
Industry
Pharmaceutical Preparations
Location
55 Cambridge Parkway, Suite 901 E, Cambridge, MA

Insiders trading volume in the past year

KalVista Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Venrock Healthcare Capital Partners III, L.P. 10%+ Owner $50M +$3.32M +7.12% Apr 9, 2025
Benjamin L. Palleiko CHIEF EXECUTIVE OFFICER, Director $8.14M -$1.44M -15% Sep 6, 2025
Thomas Andrew Crockett CEO, Director $4.65M Feb 17, 2024
Paul K. Audhya Chief Medical Officer $3.3M -$349K -9.57% Aug 22, 2025
Christopher Yea Chief Development Officer $2.17M -$778K -26.4% Aug 22, 2025
Edward P. Feener Chief Scientific Officer $1.2M May 17, 2024
Brian Piekos Chief Financial Officer $786K Feb 21, 2025
Nicole Sweeny Chief Commercial Officer $433K -$44.5K -9.31% Aug 22, 2025
Michael David Smith Senior VP, Development $127K May 17, 2022
Andreas Maetzel Senior Vice President, Medical May 26, 2021
Martin Edwards Director Sep 30, 2021
Brian JG Pereira Director Oct 1, 2025
Laurence Reid Director Nov 23, 2024
Bethany Sensenig Director Oct 1, 2025
Daniel B. Soland Director Sep 30, 2021
William Fairey Director Oct 1, 2025
Edward W. Unkart Director Oct 1, 2025
Patrick Treanor Director Oct 1, 2025
Albert Cha Director Sep 26, 2023
Nancy Stuart Director Oct 1, 2025

Recent Insider Transactions by Companies or Individuals for KalVista Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.